Orla Hardiman

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Incidence of amyotrophic lateral sclerosis in Europe

Giancarlo Logroscino, Bryan Traynor, Orla Hardiman et al. · Journal of Neurology Neurosurgery & Psychiatry · 2009 · 747 citations

ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis

Matthew Greenway, Peter M. Andersen, Carsten Russ et al. · Nature Genetics · 2006 · 654 citations

Neurodegenerative Diseases, Ang Mutations, Mendelian Disorder +8

The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study

Julie Phukan, Marwa Elamin, Peter Bede et al. · Journal of Neurology Neurosurgery & Psychiatry · 2011 · 645 citations

Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model

Henk-Jan Westeneng, Thomas P. A. Debray, Anne E Visser et al. · The Lancet Neurology · 2018 · 492 citations · Full text

Prognostic Assessment, Neurodegenerative Diseases, Personalised Prediction Model +12